No Data
No Data
Cautious Hold Rating on Sanofi Due to Safety Concerns and Limited Growth Prospects for Qfitlia
Sanofi Consumer Healthcare India Limited Announces Postal Ballot Results
Top FDA Vaccine Official Resigns Citing RFK Jr.'s 'Misinformation and Lies'
Sanofi Says With Qfitlia Approval, FDA Also Cleared Siemens Healthineers' Innovance Antithrombin Assay As Companion Diagnostic For Qfitlia
Sanofi Hemophilia Treatment Receives FDA Approval
FDA Approves Novel Treatment for Hemophilia A or B, With or Without Factor Inhibitors